Last reviewed · How we verify
NCT03904485: AMI-SPK
Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation
trial testing cardiac magnetic resonance(CMR) T2 mapping in Simultaneous Pancreas-kidney Transplantation in 50 participants. Status unknown.
1 April 2020
Quick facts
| Lead sponsor | Tianjin First Central Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 April 2019 |
| Primary completion | 1 April 2020 |
| Estimated completion | 1 April 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- cardiac magnetic resonance(CMR) T2 mapping
Conditions studied
- Simultaneous Pancreas-kidney Transplantation — all drugs for Simultaneous Pancreas-kidney Transplantation →
- Diabetic Cardiomyopathy — all drugs for Diabetic Cardiomyopathy →
Sponsor
Tianjin First Central Hospital
Who can join
Adults 20 to 60, any sex, with Simultaneous Pancreas-kidney Transplantation or Diabetic Cardiomyopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Diabetic cardiomyopathy( DCM) is a major complication of diabetes and is a common cardiovascular complication independent of coronary artery disease and hypertension．Trial to assess of myocardial injury in recipients of simultaneous pancreas and kidney transplantation by nuclear magnetic T２ mapping technology.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03904485
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Tianjin First Central Hospital trials
Trials by the same sponsor.
- NCT06598228 — Acute Kidney Injury and Recovery Mode in Pediatric Liver Transplantation · completed
- NCT05752058 — Risk Factors for Early Acute Lung Injury After Liver Transplantation in Children · unknown
- NCT05926076 — COVID-19 Infection · unknown
- NCT05807802 — FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis · unknown
- NCT05783518 — Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03904485 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin First Central Hospital
- Last refreshed: 5 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03904485.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing